share_log

ZyVersa Therapeutics | POS EX: Post-effective amendment filed solely to add exhibits to a registration statement

SEC announcement ·  Apr 28, 2023 23:19
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.